selected publications
- BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 2023 Academic Article GET IT
-
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.
Cancer discovery.
2023
Editorial Article
GET IT
Times cited: 3 -
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.
Blood cancer discovery.
2023
Editorial Article
GET IT
Times cited: 1 -
Interprofessional learning in a student-run dental clinic: The effect on attitudes of students in oral healthcare.
Journal of interprofessional care.
2022
Academic Article
GET IT
Times cited: 1 -
Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations.
Blood.
2021
Academic Article
GET IT
Times cited: 7 - Mentoring for future physician scientists. Nature immunology. 2021 Letter GET IT
-
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.
Blood cancer discovery.
2021
Academic Article
GET IT
Times cited: 14 -
Surveillance of Myelodysplastic Syndrome via Migration Analyses of Blood Neutrophils: A Potential Prognostic Tool.
Journal of immunology (Baltimore, Md. : 1950).
2018
Academic Article
GET IT
Times cited: 9 -
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis.
Annals of hematology.
2018
Academic Article
GET IT
Times cited: 4